A detailed, realistic representation of a group of UK cancer patients ranging in age from 35-69. Depicts medical professionals discussing results of cancer screenings with patients. The image captures a sense of hope and advancement in cancer prevention and treatment.
Understanding cancer trends over time is crucial for shaping effective health strategies. This study focuses on cancer incidence and mortality across the UK from 1993 to 2018, targeting adults aged 35-69. Researchers aimed to explore the impact of screening programs, lifestyle changes, and medical advancements on cancer outcomes.
Jon Shelton, a lead researcher, emphasized the importance of the chosen age range: “Focusing on individuals between 35 and 69 years old allows us to capture more reliable cancer trend data.” He also noted that cancer incidence in this demographic is indicative of future patterns in older populations.
The study reveals that cancer rates have been influenced by the introduction of screening programs for breast, cervical, and bowel cancer. “Screening efforts have had a profound impact on early diagnosis and prevention,” said Ewa Zotow, another contributor to the study. Notably, the national screening programs for cervical cancer and breast cancer, both introduced in the late 1980s, showed a marked effect on incidence and mortality rates.
One significant finding was the decline in lung cancer incidence among men, attributed to a decrease in smoking rates. However, lung cancer remains one of the leading causes of cancer-related deaths. “The decrease in smoking is an encouraging sign, but we still have a long way to go,” remarked Lesley Smith.
Interestingly, prostate cancer trends showed a complex picture. The absence of a formal screening program for prostate cancer in the UK likely affected these trends. As Shane A Johnson explained, “While prostate-specific antigen testing is available, its inconsistent use has led to variations in prostate cancer diagnosis rates.”
Breast cancer rates, while benefiting from early detection due to screening, saw a rise in overall incidence. The researchers believe this increase could be linked to hormone replacement therapy and delayed childbirth. “These factors are known to affect breast cancer risk, but improved early diagnosis is likely why mortality rates haven’t risen as sharply,” explained Catherine S Thomson.
The study concludes by underlining the need for continued efforts in prevention, early detection, and treatment improvement. Amar Ahmad stated, “We must remain vigilant in monitoring trends to adapt our health policies accordingly.”
Screening programs are clearly a double-edged sword, according to Lars Murdock. While they have undoubtedly saved lives, they have also identified cancers that may not have required intervention. “There’s an ongoing debate about overdiagnosis and overtreatment,” added Diana Nagarwalla.
David Forman, one of the supervising authors, pointed out the importance of using this long-term data for future predictions. “Understanding past and present cancer trends allows us to make more informed decisions about resource allocation and healthcare priorities for the future,” he said.
Citation:
Shelton J, Zotow E, Smith L, et al. 25 year trends in cancer incidence and mortality among adults aged 35-69 years in the UK, 1993-2018: retrospective secondary analysis. BMJ. 2023;384. doi:10.1136/bmj-2023-076962.
License:
This content is generated from the original article original article and it’s under Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial.
